Literature DB >> 12410214

Underlying characteristics of patients harboring highly resistant Acinetobacter baumannii.

Siham Mahgoub1, Jimmie Ahmed, Aaron E Glatt.   

Abstract

BACKGROUND: Highly resistant (HR) Acinetobacter baumannii (AB) are frequently hospital-acquired and may be important causes of severe nosocomial infections.
OBJECTIVE: Determine risk factors associated with such colonization/infection.
METHOD: Retrospective review in 2000 of all AB isolates from sterile (blood, cerebrospinal fluid [CSF]) and nonsterile (respiratory, urine, and miscellaneous) sites. HR was defined as resistance to amikacin and/or imipenem and/or ampicillin-sulbactam. Isolates were analyzed as representing infection or colonization. A database including prior hospitalization, prior antibiotic use, nursing home residency, and procedures undergone was compiled.
RESULTS: One hundred twenty-two cases of AB were identified. Eighty-four met the definition of HR; 6 (4.9%) were completely resistant to all antibiotics. Four (4.7%) isolates were from sterile body sites (3 blood, 1 CSF); 43 (51.2%) were from respiratory sites; 20 (23.8%) were from urinary sites; and 17 (20.2%) were from "other" sites. Only 4 (20%) of the urinary, 6 (35.2%) of the miscellaneous, and 23 (53.4%) of the respiratory isolates were deemed true pathogens; all blood/CSF isolates were considered pathogens. Associated risk factors included prior antibiotic usage (71%); prior hospitalization (24%); prior nursing home residency (34%); ventilator use (77%); tracheostomy placement (56%); and Foley catheterization (85%). Twenty-seven (63%) of 43 respiratory, 8 (40%) of 20 urinary, and 6 (35%) of 17 "other" body isolates were treated. Outcome was not statistically significant in treated versus untreated patients. All patients with CSF/blood isolates underwent successful microbiologic eradication with 50% survival. The overall mortality rate was 10%.
CONCLUSION: Antibiotics, Foley catheters, and tracheostomy/ventilator usage were strongly associated with AB isolation. Prior hospitalization and nursing home residency were less common risk factors. Outcome was not different in treated versus untreated patients, indicating colonization is a marker of severe illness but is not necessarily causal.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12410214     DOI: 10.1067/mic.2002.122648

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  8 in total

1.  Epidemiology and resistance features of Acinetobacter baumannii isolates from the ward environment and patients in the burn ICU of a Chinese hospital.

Authors:  Yali Gong; Xiaodong Shen; Guangtao Huang; Cheng Zhang; Xiaoqiang Luo; Supeng Yin; Jing Wang; Fuquan Hu; Yizhi Peng; Ming Li
Journal:  J Microbiol       Date:  2016-08-02       Impact factor: 3.422

2.  Gold nanoparticle-DNA aptamer-assisted delivery of antimicrobial peptide effectively inhibits Acinetobacter baumannii infection in mice.

Authors:  Jaeyeong Park; Eunkyoung Shin; Ji-Hyun Yeom; Younkyung Choi; Minju Joo; Minho Lee; Je Hyeong Kim; Jeehyeon Bae; Kangseok Lee
Journal:  J Microbiol       Date:  2021-12-29       Impact factor: 3.422

3.  Multidrug resistant Acinetobacter baumannii: a descriptive study in a city hospital.

Authors:  Lemuel L Dent; Dana R Marshall; Siddharth Pratap; Robert B Hulette
Journal:  BMC Infect Dis       Date:  2010-07-07       Impact factor: 3.090

4.  Molecular epidemiology of sequential outbreaks of Acinetobacter baumannii in an intensive care unit shows the emergence of carbapenem resistance.

Authors:  Raffaele Zarrilli; Margherita Crispino; Maria Bagattini; Elena Barretta; Anna Di Popolo; Maria Triassi; Paolo Villari
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

5.  Acquisition of a plasmid-borne blaOXA-58 gene with an upstream IS1008 insertion conferring a high level of carbapenem resistance to Acinetobacter baumannii.

Authors:  Te-Li Chen; Roy Chen-Chih Wu; Men-Fang Shaio; Chang-Phone Fung; Wen-Long Cho
Journal:  Antimicrob Agents Chemother       Date:  2008-04-28       Impact factor: 5.191

6.  Biological cost of different mechanisms of colistin resistance and their impact on virulence in Acinetobacter baumannii.

Authors:  Alejandro Beceiro; Antonio Moreno; Nathalie Fernández; Juán A Vallejo; Jesús Aranda; Ben Adler; Marina Harper; John D Boyce; Germán Bou
Journal:  Antimicrob Agents Chemother       Date:  2013-11-04       Impact factor: 5.191

Review 7.  Epidemiology and Mechanisms of Resistance of Extensively Drug Resistant Gram-Negative Bacteria.

Authors:  Emily M Eichenberger; Joshua T Thaden
Journal:  Antibiotics (Basel)       Date:  2019-04-06

Review 8.  Infection Control Programs and Antibiotic Control Programs to Limit Transmission of Multi-Drug Resistant Acinetobacter baumannii Infections: Evolution of Old Problems and New Challenges for Institutes.

Authors:  Chang-Hua Chen; Li-Chen Lin; Yu-Jun Chang; Yu-Min Chen; Chin-Yen Chang; Chieh-Chen Huang
Journal:  Int J Environ Res Public Health       Date:  2015-07-30       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.